# Community versus institutionalised care for people with severe mental illness in five countries in Southeast Europe: pooled analysis of five randomised trials

**Authors:** Laura Shields-Zeeman, Filip Smit, Ben Wijnen, Catharina Roth, Michel Wensing, Ionela Petrea, Felix Bolinski, Felix Bolinski, Stojan Bajraktarov, Jovo Dedovic, René Keet, Martina Rojnic Kuzman, Vladimir Nakov, Raluca Nica, Antoni Novotni, Aleksandar Tomcuk, Tatjana Djurisic, Guadalupe Morales, Tiberiu Rotaru Anghelescu

PMC · DOI: 10.1136/bmjgh-2024-018594 · BMJ Global Health · 2025-10-23

## TL;DR

Community-based mental healthcare improved functioning and quality of life for people with severe mental illness in five Southeast European countries compared to traditional care.

## Contribution

Demonstrated the effectiveness of community mental healthcare across diverse healthcare systems in Southeast Europe.

## Key findings

- CMH reduced disability scores by 4.55 compared to treatment as usual after 18 months.
- Quality of life improved by 0.07 utility, equivalent to 25 additional days in full health.
- Positive effects were consistent across all five countries and all WHODAS subdomains.

## Abstract

The RECOVER-E project implemented community-based mental healthcare (CMH) oriented at functional recovery in people with schizophrenia, bipolar and severe major depressive disorder in five countries: Bulgaria, Croatia, Montenegro, North Macedonia and Romania, with the aim to shift care from institutions to communities.

To evaluate the effectiveness of CMH under real-world circumstances across various healthcare ecologies and contexts.

A randomised comparison of CMH versus treatment as usual (TAU) based on pooled data from all five RECOVER-E trials (N=931). Outcomes were personal and social role functioning (WHO Disability Assessment Schedule, WHODAS 2.0) and health-related quality of life (EuroQoL-5 Dimensions-3 Levels) at baseline, 12 and 18 months postbaseline. Intention-to-treat analysis was conducted with mixed modelling and a sensitivity analysis adjusted for the impact of COVID-19 on healthcare delivery and outcomes.

At 18-month follow-up, CMH had a 4.55 lower WHODAS disability score than TAU, which was significant (b=−4.55, SE=1.21, z=−3.75, p<0.001), and improved quality of life by 0.07 utility (b=0.07, SE=0.014, z=4.56, p<0.001) equivalent to an additional 25 days in full health. Similar effects were observed in each of the five countries and for all WHODAS subdomains (cognition, mobility, self-care, getting along with people, life activities, participation). Sensitivity analyses adjusting for the confounding effect of COVID-19 showed similar effects.

Recovery-oriented CMH for people with severe mental illness was effective in improving functioning and quality of life for people with schizophrenia, bipolar disorder and severe depression in five South-Eastern European countries and could be implemented across different health systems.

Bulgaria: NCT03922425, Croatia: NCT03862209, Macedonia: NCT03892473, Montenegro: NCT03837340, Romania: NCT03884933.

## Linked entities

- **Diseases:** schizophrenia (MONDO:0005090), bipolar disorder (MONDO:0004985)

## Full-text entities

- **Diseases:** major depressive disorder (MESH:D003865), schizophrenia (MESH:D012559), bipolar (MESH:D001714), depression (MESH:D003866), mental illness (MESH:D001523), COVID-19 (MESH:D000086382)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12551481/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12551481/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12551481/full.md

---
Source: https://tomesphere.com/paper/PMC12551481